A phase i randomized therapeutic MVA-B vaccination improves the magnitude and quality of the T cell immune responses in HIV-1-infected subjects on HAART

Carmen Elena Gómez, Beatriz Perdiguero, Juan García-Arriaza, Victoria Cepeda, Carlos Óscar Sánchez-Sorzano, Beatriz Mothe, José Luis Jiménez, María Ángeles Muñoz-Fernández, Jose M. Gatell, Juan Carlos López Bernaldo De Quirós, Christian Brander, Felipe García, Mariano Esteban Esteban

    Research output: Contribution to journalArticleResearchpeer-review

    16 Citations (Scopus)

    Fingerprint Dive into the research topics of 'A phase i randomized therapeutic MVA-B vaccination improves the magnitude and quality of the T cell immune responses in HIV-1-infected subjects on HAART'. Together they form a unique fingerprint.

    Agriculture & Biology

    Medicine & Life Sciences

    Chemical Compounds